BOT with two recent announcements. I can’t help but wonder if those that sold out are either impatient to wait for the share price to recover or fearful that there would be no recovery. Is this an example of the modern ability for retail holders to sell at the touch of a button? Is it a sign of the desire to want to 2x or 3x at all opportunities.

The recent announcements indicate it’s full steam ahead as they wait for resubmission of the required information in late 2023 and then approval in mid 2024.

17/10: FDA approved SOFDRA as trade name

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02726116-6A1174479?access_token=83ff96335c2d45a094df02a206a39ff4

24/20: BOT partners with TeleHealth provide UpScript.

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02729138-6A1175835?access_token=83ff96335c2d45a094df02a206a39ff4

Note: Held IRL started a position after the recent price drop due to the labelling decision. Seemed like an irrational decision. @mikebrisy post regarding FDA labelling issues helped further my conviction that this is a potential early Xmas gift opportunity.